Profile of Micronutrients, Electrolytes, Haematology and CD4 Count in HIV Infected Subjects on Highly Active Antiretroviral Therapy doi.org/10.26538/tjnpr/v2i1.9
Main Article Content
Abstract
Human Immunodeficiency Virus (HIV) infection compromises the immune status, diminishes micronutrients availability and causes electrolyte imbalance in individuals. Highly Active Antiretroviral therapy (HAART) is currently used in the management of HIV patients. This work was designed to determine the profile of micronutrients, electrolytes, haematology and CD4 Count in HIV Infected Subjects on HAART. One hundred and sixty-three (thirty-six males and one hundred and twenty-seven females) subjects of whom one hundred and eleven (twenty-five males and eighty-six females) were HIV positive (grouped as Pre-HAART subjects). Fifty-two (eleven males and forty-one females) HIV- negative controls were used in this study. Blood samples (10mL) were collected by veni-puncture from Pre-HAART subjects and the control group. 5 mL was added to clean sterile bottle to yield serum for micronutrient and electrolyte determination while 5 mL were added to EDTA bottles for haematological and CD4 count. The HIV subjects were then placed on HAART for six months. Blood samples were then collected. Our findings showed a significant (p ≤ 0.05) increase in CD4 count and the haematological parameters of HAART subjects when compared to pre-HAART HIV subjects. The same results were obtained for the
serum levels of vitamins A and C, zinc, copper, selenium and potassium ion. However, the serum levels of vitamin E, sodium and chloride ions did not show any significant different (p ≥ 0.05) between the pre-HAART and HAART subjects. Mineral supplements rich in vitamin E, sodium and chloride ions may be required in combination with HAART in HIV management.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Bailes E, Gao F, Bibollet-Ruche F, Courgnaud V, Peeters M, Marx PA, Hahn BH, Sharp PM. Hybrid origin of SIV in chimpanzees. Sci 2003; 300:1713.
Palella FJ, Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr.2006; 43(1):27-34.
Berns JS1, Kasbekar N. Highly active antiretroviral therapy and the kidney: an update on antiretroviral medications for nephrologists. Clin J Am Soc Nephrol. 2006; 1(1):117-129.
Moore DM1, Hogg RS, Yip B, Wood E, Tyndall M, Braitstein P, Montaner Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy. J Acquir Immune Defic Syndr. 2005; 40(3):288-293.
UNAIDS. Epidemiological facts sheets on HIV and AIDS, epidemiological core data on epidemiology and response. UNAIDS. 2008; http://data.unaids.org/pub/GlobalReport/2008 /jc1511_gr08_executivesummary_en. Retrieved on 23-05-2017.
Allard JP, Aghdassi E. Chau J. Effects of vitamin E and C supplementation on oxidative stress and viral load in HIVinfected subjects. AIDS, 1998; 12:1653-1659.
Kassu A, Yabutani T, Mahmud ZH, Mohammad A, Nguyen N, Huong BTM, Hailemariam G, Diro E, Ayele B, Wondmikun Y, Motonaka J, Ota F. Alterations in serum levels of trace elements in tuberculosis and HIV infections. Eur J Clin Nutr. 2006; 60:580-586.
Khalili H, Soudbakhsh A, Hajiabdolbaghi M, DashtiKhavidaki S, Poorzare A, Saeedi AA, Sharififar R. Nutritional status and serum zinc and selenium levels in Iranian HIV infected individuals. BMC Infect Dis. 2008; 8:165.
Muthuraj M, Kamatchiyammal S, Usharani B. Serum Znic, Calcium and Albumin levels in Pulmonary Tuberculosis patients co-infected with HIV. Global J. of Biotech & Biochem.2010; 15(9):27-35.
Baum MK, Shor-Posner G, Lai S, Zhang G, Flecher MA, Saubelich H, Page. JG. High risk of HIV related motality is associated with selenium deficiency. J Acqiur Immune Defic Syndr Hum Retrovirol. 2010; 15:320-374.
Drain PK, Kupka R, Mugusi F, Fawzi WW. Micronutrients in HIV positive persons receiving HAART. Am J Clin Nutr, 2007;85(2):333-345.
Gange SJ, Lau B, Phair J, Riddler SA, Detels R, Margolick JB. Rapid declines in total lymphocyte count and hemoglobin inHIV infection begin at CD4 lymphocyte counts that justify antiretroviral therapy. AIDS. 2003; 17:119-121.
Muluneh A, Fessahaye A. Hematologic abnormalities among children on HAART in Jimma University Specialized Hospital, Southwestern Ethiopia. Ethiop J Health Sci. 2009; 19 (2):83-89.
Dikshit B, Wanchu A, Sachdeva KR, Sharma A, Das R. Profile of hematological abnormalities of Indian HIV infected individuals. BMC Blood Dis. 2009; 9:5-10.
National Population Commission and National Bureau of Statistics. Projected population estimate 2016.
https://www.citypopulation.de/php/nigeriaadmin.php?adm1id=NGA033: Retrieved on 23-05-2017.
Lawal S, Bilbis DB, Idowu YS, Mansur L, Chibueze HN. Serum levels of antioxidant vitamins and mineral elements of human immunodeficiency virus positive subjects in Sokoto, Nigeria. Ann Afr Med 2010; 9(4)235-239.
Stephensen CB, Marquis GS, Jacob RA, Kruzich, LA., Douglas, S. D. and Wilson, C. M. Vitamins C and E in adolescents and young adults with HIV infection. Am J Clin Nutr, 2006; 83(4):870-879.
Anyabolu HC, Adejuyigbe EA, Adeodu OO. Serum Micronutrient Status of Haart-Nave, HIV Infected Children in
South Western Nigeria: A Case Controlled Study. AIDS Res Treatment 2014; 10:351043- 351048.
Nwegbu MM, Egua MO, Ogwu OS. Comparative study of plasma zinc and selenium levels amongst Human Immunodeficiency Virus (HIV) positive and negative subjects. Afr J Food Sci Tech. 2015; 6(8):253-258.
Powanda MC, Beisel WR. Hypothesis: leukocyte endogenous mediatorrendogenous pyrogenrlymphocyte activating factor
modulates the development of nonspecific and specific immunity and affects nutritional status. Am J Clin Nutr. 1982; 35:762-768.
Kedzierska K, Crowe SM. Cytokines and HIV: Interactions and clinical implications. Antivir Chem Chemother. 2001; 12:133-150.
Ibs KH, Rink L. Zinc-altered immune function. J Nutr. 2003; 133:1452S-1456S.
Mohamed A, Abd E, Elhashimi E, Hassan SM, Bakhit GA, Modawe NE, Shrif MA. Assessment of plasma Zinc and copper
Levels among Sudanese HIV Patients in Khartoum State. IJAPBC. 2014; 3(2):395-399.
Bobat R, Coovadia H, Stephen C. “Safety and efficacy of zinc supplementation for children with HIV-1 infection in South
Africa: a randomised double-blind placebo-controlled trial.” The Lancet 2005; 366(9500):1862-1867.
Ogunro PS, Ogungbamigbe TO, Elemie PO, Egbewale BE, Adewole TA. “Plasma selenium concentration and glutathione
peroxidase activity in HIV-1/AIDS infected patients: a correlation with the disease progression,” Nig Pg Med J. 2006: 13(1):1-5.
Tang AM, Forrester J, Spiegelman D. Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral
therapy. J Acquir Immune Defic Syndr; 2002; 31:230-236.
Steinhart CR. HIV-associated wasting in the era of HAART: a practice-based approach to diagnosis and treatment. AIDS Read. 2001; 11:557-569.
Xu XM, Carlson BA. Grimm TA. Rhesus monkey simian immunodeficiency virus infection as a model for assessing the
role of selenium in AIDS. J Acquir Immune Defic Syndr; 2002: 31:453-463.
Ansgar R. Human Immunodeficiency Virus (HIV) and renal function. J Clin. 2007: 57(2):15-89.
Ross MJ, Klothman PE. HIV-associated nephropathy. Aids; 2004; 18:1089-1099.31. Eshiet EM, Jemikalajah DJ, Okogun GRA. Plasma urea and
electrolytes profile in different stages of HIV infection in Ekpoma, Nigeria. Afr J Cell Path. 2015; 4:1-5.
Ziegler PD. Clinical diagnosis and treatment. Migration of potassium into cells. J Clin Med. 1996; 90:180-200.
Kleyman TR, Bean A, Roberts C, LING BM. Dehydration symptoms benefits of water influx-signs of fluid imbalance. Ann Intern Med. 2006; 122:103-106.
Basu A, Ghosh K, Banerjee K.: Bone marrow involvement in HIV infection: light, electron and immuno electron microscopic
studies. Ind J Hematol Blood Trans. 1999; 17(4):76–86.
Wuba O, Quaye L, Amidu N, Mensah, A.: Prevalence of anemia and immunological markers among Ghanaian HAART naïve HIV patients and those on HAART. Afr Health Sci. 2011; 11(1):2-15.
Munyazesa E, Emile I, Mutimura E. Assessment of haematological parameters in HIV-infected and uninfected Rwandan women: a cross-sectional study. BMJ Open 2012; 2:e001600.
Anyaechie USB, Nneli RO, Amadi P, Nwobodo ED. Leukocyte profile in HIV Positive adults in Owerri, Nigeria. Nigerian Medical Practitioner, 2005; 47:61-64.
Balleari E, Timitilli S, Puppo F, Gaffuri L, Mussell FC, Rizzo E. Impaired invitro growth of peripheral blood hematopoietic
progenitor cells in HIV infected patients: evidence of an inhibitory effect of autologous T lymphocytes. Ann Haematol.1991; 63:320-325.
Erhabor O, Ejele OA, Nwauche CA. Some hematological parameters in human immunodeficiency virus (HIV) infected Africans: the Nigerian perspective. Niger J Med. 2005; 14:33-38.
Esan AJ, Omisakin CT, Fasakin k, Oyedele TE, Oyegue k, Ogunbusuyi B. Assessment of some haematological and immunological parameters in HIV-infected patients on HAART and HAART naïve in Ekiti State. Br J Adv Acad Res. 2005; 4(1):54-61.
Vannappagari V, Nkhoma ET, Atashili, J. Prevalence, severity and duration of thrombocytopenia among HIV patients in the era of highly active antiretroviral therapy. Platelets 2011; 22:611–618.
Kouri YH, Borkowsky W, Nardi M, Karpatkin S, Basch RS: Human megakaryocytes have a CD4 molecule capable of binding human immunodeficiency virus-1. Blood 1993; 81(10):2664-2670.
Liebman HA Viral-associated immune thrombocytopenic purpura. Hematology the Education Program of the American Society of Hematology. Am Soc Hematol Edu Prog. 2008; 1:212-218.
Owiredu W, Quaye L, Amidu N. Addai-Mensah, O. Prevalence of anaemia and immunological markers among Ghanaian
HAART-naïve HIV-patients and those on HAART. Afr Health Sci, 2011; 11(1):2-15.
Mildvan D, Creagh T, Leitz G. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human immunodeficiency- virus infected patients: findings of the anemia prevalence study. Curr Med Res Opin,2007; 23(2):343–355.
Erhabor O, Ejele OA, Nwauche CA. Some hematological parameters in human immunodeficiency virus (HIV) infected
Africans: the Nigerian perspective. Niger J Med.; 2005; 14:33-38